Exergaming to Increase Physical Activity in Overweight/Obese Children and Adolescents

Not Applicable

Terminated

• Conditions: Obesity
• Interventions: Behavioral: Exergaming

• Registration Number: NCT04122950
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

The primary purpose of this study is to examine the effects of regular exergaming for 8 weeks in 24 overweight/obese children and adolescents (10-17 years) on maximal aerobic fitness (VO2max) and physical activity levels measured before and after (8 weeks) intervention period, and in addition at follow-up (12 weeks). We also wish to investigate the effects on markers of cardio metabolic health and body composition, measured at baseline, 8 weeks and 12 weeks follow-up.

Also, the participants gaming frequency will be registered throughout the 8 week period, as well as during the follow-up between 8 and 12 weeks. Aim of this study is to investigate if access to this game can provide health benefits for overweight/obese children and adolescents.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-09-30
• Study First Submitted QC: 2019-10-09
• Study First Posted: 2019-10-10
• Study Start: 2020-02-24
• Status Verified: 2022-03
• Primary Completion: 2022-03-28
• Study Completion: 2022-03-28
• Last Update Submitted: 2022-03-29
• Last Update Posted: 2022-04-07

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

• Defined as overweight/obese for age and sex
• Able to ride a bike for up to 60 minutes

Exclusion Criteria

• Known cardiovascular disease
• Taking beta-blockers or anti-arrhythmic drugs
• Other diseases that restrict them from doing High-Intensity Training

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Exergaming	Exergaming	The participants in the Exergaming group will use the PlayPulse exergame for 45 minutes a minimum of two times per week for 8 weeks. Between 8 and 12 weeks the exergaming group will be provided with free access to the exergame but without the two mandatory exergaming sessions

Primary Outcome Measures

Name	Time	Method
Daily time physical activity (moderate, vigorous and very vigorous)	12 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and at 12 weeks.

Secondary Outcome Measures

Name	Time	Method
Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)	8 and 12 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Bioelectrical impedance	8 and 12 weeks	Body composition assessed using bioelectrical impedance analysis (InBody 720)
Fasting triglycerides, LDL-, HDL- and Total cholesterol, as blood marker of cardiometabolic health	8 and 12 weeks
Daily average energy expenditure	8 and 12 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Daily average number of steps	8 and 12 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)	8 and 12 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
glucose response to a 2 hour glucose tolerance test, as blood marker of cardiometabolic health	8 and 12 weeks
VO2max	8 and 12 weeks	Maximal Aerobic Capacity
Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)	8 and 12 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Daily average total physical activity duration	8 and 12 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Daily time in vigorous intensity activity	8 and 12 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Blood Pressure	8 and 12 weeks
Fasting circulating glucose, as blood marker of cardiometabolic health	8 and 12 weeks
Circulating insulin concentration, as blood marker of cardiometabolic health	8 and 12 weeks
Daily time physical activity (moderate, vigorous and very vigorous)	8 weeks	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and at 8 weeks

Trial Locations

Locations (1)

Department of Circulation and Medical Imaging; 🇳🇴 Trondheim, Norway